Risk of Share-Value Dilution from the Exercise of Stock Acquisition Rights
First written in FY2023. 4 of 8 entries say "Worsened", first in FY2024-Q3. Latest entry: FY2026.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026MitigatedAnnual report
「As of the end of the fiscal year, the number of potential shares attributable to stock acquisition rights was 499,280, equivalent to 4.11% of the total 12,140,258 issued shares.」
The potential share ratio declined from 5.25% in the previous fiscal year to 4.11%. - FY2025MitigatedAnnual report
「As of the fiscal year-end, the number of potential shares from stock acquisition rights was 572,010, equivalent to 5.25% of the 10,899,888 issued shares.」
Potential shares declined from 773,020, or 7.1%, in the previous disclosure to 572,010, or 5.25%. - FY2025-H1WorsenedAnnual report
「Increase resulting from the exercise of stock acquisition rights」
Issued shares increased from 10,808,598 to 10,851,218 through the exercise of stock acquisition rights. - FY2024WorsenedAnnual report
「As of the fiscal year-end, the number of potential shares from stock acquisition rights was 773,020, equivalent to 7.1% of the 10,807,808 issued shares.」
Potential shares increased from 713,940, or 6.6%, in the previous disclosure to 773,020, or 7.1%. - FY2024-Q3WorsenedAnnual report
「The increase resulted from the exercise of stock acquisition rights (stock options).」
Issued shares increased by 32,970 from January to March 2024 through the exercise of stock acquisition rights. In addition, 121,680 fourth-series stock acquisition rights, representing 121,680 common shares, were issued, adding potential dilution. - FY2023First statedAnnual report
「As of the filing date, the number of potential shares from stock acquisition rights was 713,940, equivalent to 6.6% of the 10,763,358 issued shares.」
The company discloses the possibility that exercise of stock options could dilute existing shareholders’ equity value.